Physician

Karl V Hakmiller, MD

According to 2025 Medicare claims, Karl Hakmiller, MD (NPI: 1285681957) practices cardiology in the Daphne-Fairhope-Foley, AL market, with the plurality of this provider's patient population coming from Baldwin, AL. This provider's primary affiliated billing organization is CARDIOLOGY ASSOCIATES OF MOBILE INC (NPI: 1689623076; TIN: 630889615) and primary practice location at 36532-2038. Hakmiller is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Hakmiller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,128 traditional Medicare patients, billed 7,069 HCPCS/CPT codes, and received $746,467 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 12,668 prescription claims across 1,711 beneficiaries totaling $2,825,550 in drug costs, led by Eliquis (Apixaban). DME data shows 11 claims. Open Payments data shows 10 records totaling $183. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $627,288 to $746,467. Similarly, Part D prescription costs have moved sharply higher in recent years, from $493,840 to $2,825,550. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $9,528 and ending at $1,816.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,310	16,246	$627,288
2016	2,419	15,341	$581,212
2017	2,275	13,024	$515,946
2018	2,199	7,328	$498,169
2019	2,254	7,895	$561,244
2020	2,093	7,309	$758,863
2021	2,021	6,820	$801,796
2022	2,162	7,574	$1,009,580
2023	2,093	6,984	$990,851
2024	2,128	7,069	$746,467

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	899	7,767	$493,840
2016	987	8,618	$794,590
2017	1,065	8,866	$916,314
2018	1,130	8,054	$869,005
2019	1,166	8,063	$1,079,584
2020	1,232	8,442	$1,271,695
2021	1,348	8,677	$1,470,489
2022	1,513	9,938	$1,821,264
2023	1,556	11,288	$2,334,234
2024	1,711	12,668	$2,825,550

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	62	$8,520
2016	11	72	$5,070
2017	N/R	40	$2,148
2018	N/R	19	$1,046
2019	N/R	63	$2,168
2020	N/R	64	$2,277
2021	N/R	12	$980
2022	N/R	30	$2,651
2023	N/R	23	$765
2024	N/R	11	$817

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	579	585	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,004	1,471	$78
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	294	295	$48
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	633	645	$8
J2785	Injection, regadenoson, 0.1 mg	251	1,005	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	761	45,356	$858,884
Xarelto	Rivaroxaban	360	24,889	$448,651
Entresto	Sacubitril/Valsartan	330	16,822	$354,546
Repatha Sureclick	Evolocumab	378	14,953	$286,511
Jardiance	Empagliflozin	341	14,189	$262,926

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	11	$817

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$183	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Karl V. Hakmiller, MD?

Tedicare shows public-source Medicare data for Karl V. Hakmiller, MD (NPI 1285681957), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Karl V. Hakmiller, MD have ACO affiliation data?

Karl V. Hakmiller, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Karl V. Hakmiller, MD?

Karl V. Hakmiller, MD is linked to CARDIOLOGY ASSOCIATES OF MOBILE INC (billing NPI 1689623076) in the available physician profile data.

Does Karl V. Hakmiller, MD have Open Payments data?

Karl V. Hakmiller, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.